| 0.21 0.002 (0.96%) | 01-29 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.33 | 1-year : | 0.46 |
| Resists | First : | 0.28 | Second : | 0.39 |
| Pivot price | 0.21  |
|||
| Supports | First : | 0.1 | Second : | 0.09 |
| MAs | MA(5) : | 0.2  |
MA(20) : | 0.22 |
| MA(100) : | 1.7 |
MA(250) : | 19.1 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 58 |
D(3) : | 57.1 |
| RSI | RSI(14): 42.2 |
|||
| 52-week | High : | 80.5 | Low : | 0.1 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SISI ] has closed above bottom band by 48.0%. Bollinger Bands are 94.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 62 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.21 - 0.21 | 0.21 - 0.21 |
| Low: | 0.11 - 0.11 | 0.11 - 0.11 |
| Close: | 0.21 - 0.21 | 0.21 - 0.21 |
Shineco, Inc. engages in processing and distributing specialized fabrics, textiles, and other byproducts derived from an indigenous Chinese plant Apocynum Venetum in the People's Republic of China. The company's specialized fabrics, textiles, and other byproducts are specialized textile and health supplement products to incorporate traditional Eastern medicines with various scientific methods. It also grows and cultivates yew trees, fast-growing bamboo willows, and scenic greening trees; and provides logistic services for agricultural products. The company is headquartered in Beijing, the People's Republic of China.
Wed, 08 Oct 2025
Shineco shares suspended from Nasdaq after delisting decision upheld - Investing.com
Wed, 20 Aug 2025
Shineco’s Bold Move: Game-Changer or Risk? - StocksToTrade
Wed, 20 Aug 2025
Shineco partners with Plus Me for blockchain-based cell tokenization - Investing.com
Wed, 20 Aug 2025
World's First Blockchain-Based Cell Asset Platform: Shineco Launches Tokenization System with Ethereum Integration - Stock Titan
Thu, 07 Aug 2025
Shineco, Inc. to Effect 50:1 Reverse Stock Split - GlobeNewswire
Wed, 11 Jun 2025
Management Confidence: Shineco Executives Launch up to $2M Open-Market Stock Purchase Program - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 7 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 900610 (%) |
| Held by Institutions | 198280 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.05e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 802.27 |
| Profit Margin | 0 % |
| Operating Margin | -9 % |
| Return on Assets (ttm) | 178.8 % |
| Return on Equity (ttm) | -10.4 % |
| Qtrly Rev. Growth | 9.6e+006 % |
| Gross Profit (p.s.) | -0.01 |
| Sales Per Share | -0.01 |
| EBITDA (p.s.) | 0.11 |
| Qtrly Earnings Growth | -6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -17291.1 |
| Price to Cash Flow | 0 |
| Dividend | 28890 |
| Forward Dividend | 45120 |
| Dividend Yield | 13757100% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|